DGAP-News: Senvion S.A. / Key word(s): IPO
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
Senvion: Final offer price set at EUR 15.75 per share
- Total offer volume amounts to EUR 294 million
- Market capitalization of EUR 1.02 billion
- Free-float expected to be approximately 28.75%
Hamburg: The current owners of Senvion S.A. ("Senvion"), Centerbridge and Arpwood, after consultation with Senvion and in coordination with the Joint Global Coordinators, have today set the final offer price for Senvion shares at EUR 15.75 per share. The Senvion shares will be traded on the regulated market (Prime Standard) of the Frankfurt Stock Exchange under the trading symbol SEN and the International Securities Identification Number (ISIN) LU1377527517 from 23 March 2016.
A total of 18,687,500 shares were placed with investors in the private placement, including 16,250,000 base shares from the holdings of the existing shareholders and an additional 2,437,500 shares, also from the holdings of the current owners, of over-allotments. In order to cover over-allotments, the selling shareholders have granted the underwriters an option to purchase up to 2,437,500 shares in addition to the base shares at the offer price (the "Greenshoe Option"). Centerbridge and Arpwood will together retain a stake of approximately 71.25% of the Company's share capital, assuming full exercise of the Greenshoe Option. The total offer volume, including over-allotments, amounts to about EUR 294 million and equates to a market capitalization of EUR 1.02 billion for Senvion.
Juergen Geissinger, CEO of Senvion, said: "We are pleased with the level of interest shown by investors in this offering and the confidence that they have placed in Senvion. The success of this offer is testament to the considerable work that has been put in place to build a market leader in the sector. Our clear objective is to build upon this success through innovation, product and client development and international expansion for the benefit of our investors and all of the stakeholders in our company."
Centerbridge and Arpwood have agreed to a lock-up period of six months, commencing on 7 March 2016 and ending six months after the closing of the private placement. Under the lock-up agreement, the pre-placement shareholders cannot sell their Senvion shares during the lock-up period without the consent of the majority of the Joint Global Coordinators. Senvion management has also committed to a lock-up period commencing on 7 March 2016 and ending six months after the closing of the private placement.
Certain statements in this press release are forward-looking statements. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial consequences of the plans and events described herein. No one undertakes any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. You should not place any undue reliance on forward-looking statements which speak only as of the date of this press release. Statements contained in this press release regarding past trends or events should not be taken as representation that such trends or events will continue in the future. The cautionary statements set out above should be considered in connection with any subsequent written or oral forward-looking statements that Senvion S.A. (the "Company"), or persons acting on its behalf, may issue.
These materials may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. These materials do not constitute an offer of securities for sale or a solicitation of an offer to purchase securities (the "Securities") of Company in the United States, Germany or any other jurisdiction. The Securities of the Company may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "Securities Act"). The Securities of the Company have not been, and will not be, registered under the Securities Act.
In the United Kingdom, this document is only being distributed to and is only directed at persons who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) (all such persons together being referred to as "Relevant Persons"). This document is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons.
Neither the Company nor any of its shareholders intend to make any public offer of shares in the Company in the United States, Germany or any other jurisdiction. It is only intended that shares will be placed with qualified investors and less than 150 non-qualified investors per EEA member state in the Federal Republic of Germany and certain other jurisdictions and subsequently admitted to trading on the regulated market segment (regulierter Markt) of the Frankfurt Stock Exchange with simultaneous admission to the sub-segment of the regulated market with additional post-admission obligations (Prime Standard) of the Frankfurt Stock Exchange. The Listing will be made on the basis of a prospectus that must be published promptly upon approval by the Commission de Surveillance du Secteur Financier (CSSF) and will be available free of charge from the Company, 25C, boulevard Royal, L-2449 Luxembourg, Grand Duchy of Luxembourg, or on the Company's website www.senvion.com.
In any EEA Member State other than the Federal Republic of Germany that has implemented Directive 2003/71/EC (together with any amendment and any applicable implementing measures in any Member State, the "Prospectus Directive") this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive.
|25C, boulevard Royal|
|Grand Duchy of Luxembourg|
|Phone:||+49 40 5555 090 3517|
|Fax:||+49 40 5555 090 3911|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Luxemburg|
|Notierung vorgesehen / intended to be listed (Frankfurt, Prime Standard)|
|End of News||DGAP News Service|